The Olympia anatomic polished cemented stem is associated with a high survivorship, excellent hip-specific functional outcome, and high satisfaction levels:follow-up of 239 consecutive patients beyond 15 years

Introduction: The Olympia femoral stem is a stainless steel, anatomically shaped, polished and three-dimensionally tapered implant designed for use in cemented total hip arthroplasty (THA). The primary aim of this study was to determine the long-term survivorship, radiographic outcome, and patient-reported outcome measures (PROMs) of the Olympia stem. Patients and methods: Between May 2003 and December 2005, 239 patients (264 THAs) underwent a THA with an Olympia stem in our institution. Patient-reported outcome measures were assessed using the Oxford Hip Score (OHS), EuroQol-5 dimensions (EQ-5D) score, and patient satisfaction at mean 10 years following THA. Patient records and radiographs were then reviewed at a mean of 16.5 years (SD 0.7, 15.3–17.8) following THA to identify occurrence of complications or revision surgery for any cause following surgery. Radiographs were assessed for lucent lines and lysis according to Gruen’s zones Results: Mean patient age at surgery was 68.0 years (SD 10.9, 31–93 years). There were 156 women (65%, 176 THAs). Osteoarthritis was the indication for THA in 204 patients (85%). All cause stem survivorship at 10 years was 99.2% (95% confidence interval [CI], 97.9%–100%) and at 15 years was 97.5% (94.6%–100%). The 15-year stem survival for aseptic loosening was 100%. Analysis of all-cause THA failure demonstrated a survivorship of 98.5% (96.3%–100%) at 10 years and 95.9% (92.4%–99.4%) at 15 years. There were 9 THAs with non-progressive lucent lines in a single Gruen zone and 3 had lines in two zones, and no patient demonstrated signs for lysis. At a mean of 10-year (SD 0.8, 8.7–11.3) follow-up, mean OHS was 39 (SD 10.3, range 7–48) and 94% of patients reported being very satisfied or satisfied with their THA. Conclusions: The Olympia stem demonstrated excellent 10-year PROMs and very high rates of stem survivorship at final follow-up beyond 15 years

Реализация программы поддержки малого бизнеса в Томской области

Объектом исследования является малое предпринимательство. Цель работы: изучение реализации программ по развитию и поддержке малого предпринимательства в Томской области. В процессе исследования проводился анализ теоретических аспектов поддержки малого бизнеса, оценка эффективности инвестиционного проекта в рамках данной программы.Object of research is the small entrepreneurship. Work purpose: studying of a program implementation on development and support small entrepreneurship in the Tomsk region. In the course of research the analysis of theoretical aspects was carried out supports of small business, an efficiency evaluation of the investment project in framework of this program

Совершенствование ценообразования на предприятии

Выпускная квалификационная работа 105 с., 7 рис., 29 табл., 22 источника. Цель работы - экономическое обоснование оптимальной цены на продукцию. В процессе исследования проводились статистические исследования. В результате исследования была разработана оптимальная цена на продукцию. Основные технологические и управленческие характеристики: организационная структура является линейной, списочная численность предприятия - 150 человек.Final qualifying work 105 p., 7 Fig., 29 tab., 22 source. Purpose - the economic rationale for the optimal prices for the products. During the study, carried out statistical studies. The study developed the optimal price for the products. Basic technological and managerial characteristics: organizational structure is linear, the headcount of the enterprise - 150 people

In human autoimmunity, a substantial component of the B cell repertoire consists of polyclonal, barely mutated IgG+ve B cells

B cells are critical for promoting autoimmunity and the success of B cell depletion therapy in rheumatoid arthritis (RA) confirms their importance in driving chronic inflammation. Whilst disease specific autoantibodies are useful diagnostically, our understanding of the pathogenic B cell repertoire remains unclear. Defining it would lead to novel insights and curative treatments. To address this, we have undertaken the largest study to date of over 150 RA patients, utilizing next generation sequencing (NGS) to analyze up to 200,000 BCR sequences per patient. The full-length antigen-binding variable region of the heavy chain (IgGHV) of the IgG B cell receptor (BCR) were sequenced. Surprisingly, RA patients do not express particular clonal expansions of B cells at diagnosis. Rather they express a polyclonal IgG repertoire with a significant increase in BCRs that have barely mutated away from the germline sequence. This pattern remains even after commencing disease modifying therapy. These hypomutated BCRs are expressed by TNF-alpha secreting IgG+veCD27−ve B cells, that are expanded in RA peripheral blood and enriched in the rheumatoid synovium. A similar B cell repertoire is expressed by patients with Sjögren's syndrome. A rate limiting step in the initiation of autoimmunity is the activation of B cells and this data reveals that a sizeable component of the human autoimmune B cell repertoire consists of polyclonal, hypomutated IgG+ve B cells, that may play a critical role in driving chronic inflammation

Исследование эффективности брейкеров для жидкостей гидроразрыва пласта

Исследование влияния биоразлагаемых брейкеров на реологические характеристики жидкостей гидроразрыва пласта.Investigation of the effect of biodegradable breakers on the rheological characteristics of fracturing fluids